Regeneron Pharmaceuticals (REGN) News Today $545.53 +3.01 (+0.55%) Closing price 04:00 PM EasternExtended Trading$548.26 +2.73 (+0.50%) As of 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock REGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Regeneron’s New Study on Advanced NSCLC: A Potential Game Changer?July 21 at 12:24 PM | tipranks.comRegeneron’s Latest NSCLC Study: A Potential Game-Changer in Cancer TreatmentJuly 21 at 12:24 PM | tipranks.comRegeneron’s Heart Failure Study: A Potential Game-Changer for InvestorsJuly 21 at 12:24 PM | tipranks.comRegeneron’s New Trial: A Game-Changer for Lung Cancer Treatment?July 21 at 12:24 PM | tipranks.comSouth Dakota Investment Council Buys New Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 21 at 6:18 AM | marketbeat.comPrivate Advisor Group LLC Purchases 1,957 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 21 at 5:52 AM | marketbeat.comMorse Asset Management Inc Acquires 2,264 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 20 at 7:32 AM | marketbeat.comAustralianSuper Pty Ltd Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 20 at 6:58 AM | marketbeat.comMassachusetts Financial Services Co. MA Boosts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 20 at 4:47 AM | marketbeat.comBalentine LLC Invests $680,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 19 at 9:18 AM | marketbeat.comVictory Capital Management Inc. Sells 42,722 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 19 at 6:15 AM | marketbeat.comEdgestream Partners L.P. Sells 6,573 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 19 at 5:18 AM | marketbeat.comCwm LLC Increases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 19 at 4:45 AM | marketbeat.comRegeneron’s New Study on Anticoagulant Alternatives: A Potential Game Changer?July 18 at 12:57 PM | tipranks.comEvergreen Wealth Management LLC Buys New Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 18 at 10:26 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Bailard Inc.July 18 at 8:41 AM | marketbeat.comWealthfront Advisers LLC Sells 1,173 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 18 at 5:58 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Boosted by Concord Wealth PartnersJuly 17, 2025 | marketbeat.comCullen Frost Bankers Inc. Has $4.36 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 17, 2025 | marketbeat.comUBS Raises Regeneron (REGN) Price Target, Maintains Neutral RatingJuly 16, 2025 | msn.comRegeneron Advances Melanoma Treatment with New Phase 2 TrialJuly 16, 2025 | tipranks.comRegeneron’s Innovative Approach in Follicular Lymphoma Treatment: A New Phase 3 TrialJuly 16, 2025 | tipranks.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Grandfield & Dodd LLCJuly 16, 2025 | marketbeat.comApollon Wealth Management LLC Has $2.22 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 16, 2025 | marketbeat.com1 Healthcare Stock on Our Buy List and 2 to Brush OffJuly 15, 2025 | finance.yahoo.comCenterBook Partners LP Sells 10,270 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 15, 2025 | marketbeat.comConcord Asset Management LLC VA Has $1.33 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 15, 2025 | marketbeat.comLeo Wealth LLC Has $748,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 15, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Sumitomo Life Insurance Co.July 15, 2025 | marketbeat.com685 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Asahi Life Asset Management CO. LTD.July 14, 2025 | marketbeat.comOVERSEA CHINESE BANKING Corp Ltd Invests $30.17 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 14, 2025 | marketbeat.comSlow Capital Inc. Buys 6,715 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 14, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Raised by Cutter & CO Brokerage Inc.July 14, 2025 | marketbeat.comMQS Management LLC Takes $450,000 Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 14, 2025 | marketbeat.comNew York State Common Retirement Fund Sells 6,846 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 14, 2025 | marketbeat.comOxbow Advisors LLC Purchases New Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 13, 2025 | marketbeat.comArizona State Retirement System Raises Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 13, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by SteelPeak Wealth LLCJuly 12, 2025 | marketbeat.comCantor Fitzgerald Has Weak Outlook for REGN FY2026 EarningsJuly 12, 2025 | americanbankingnews.comRegeneron Pharmaceuticals (NASDAQ:REGN) Given New $584.00 Price Target at UBS GroupJuly 11, 2025 | marketbeat.comRegeneron’s Cemiplimab Study: A New Hope for Skin Cancer Treatment?July 11, 2025 | tipranks.comRegeneron Pharmaceuticals Launches Long-Term Follow-Up Study on Gene Modified T Cell TherapyJuly 11, 2025 | tipranks.comRegeneron’s REGN7544: A Promising Study in Sepsis-Induced HypotensionJuly 11, 2025 | tipranks.comRegeneron’s DB-OTO Gene Therapy Study: A Promising Step for Hearing Loss TreatmentJuly 11, 2025 | tipranks.comEnvestnet Asset Management Inc. Purchases 25,589 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)July 11, 2025 | marketbeat.comLeerink Partnrs Has Bearish Estimate for REGN Q2 EarningsJuly 11, 2025 | americanbankingnews.comMorgan Stanley Has Lowered Expectations for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock PriceJuly 10, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Mcdonald Capital Investors Inc. CAJuly 10, 2025 | marketbeat.comRegeneron Pharmaceuticals: My Highest Conviction Pharma Pick For 2025July 10, 2025 | seekingalpha.comREGN FY2026 EPS Estimate Lowered by Cantor FitzgeraldJuly 10, 2025 | marketbeat.com Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Media Mentions By Week REGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼1.370.61▲Average Medical News Sentiment REGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼2933▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Moderna News Intellia Therapeutics News Vir Biotechnology News Vertex Pharmaceuticals News AbbVie News Eli Lilly and Company News Merck & Co., Inc. News Pfizer News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
